Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2828PDF: 834HTML: 2336 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4680PDF: 1820HTML: 1340 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1876PDF: 1080HTML: 1892Tables: 222 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1729HTML: 708PDF: 925 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3917PDF: 1318HTML: 5097Incidence age-standardized rates for HL across the Mediterranean basin: 259 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2418PDF: 890HTML: 1707Figure 1: 259Table 1: 258 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1587PDF: 1013HTML: 266 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2715PDF: 877HTML: 5395 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2453PDF: 1908HTML: 1065 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3472PDF: 1014HTML: 4648 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1574PDF: 791HTML: 4604Figure 1: Chest radiograph: 269Figure 2: Flow cytometer analysis of pleural fluid: 240 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2023PDF: 1106HTML: 261 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
2157PDF: 491HTML: 248 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3791PDF: 2642HTML: 1685 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2628PDF: 862HTML: 1756 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3268PDF: 959HTML: 7319Kost Fig1: 233Kost Fig 2: 220Kost Fig3: 234Kost Fig 4: 245Kost Fig5: 241Kost fig 6: 229 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2472PDF: 648HTML: 383 -
OMENTAL SPLENOSIS MIMICKING PERITONEAL CARCINOMATOSIS
239PDF: 232HTML: 41 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2076PDF: 858HTML: 621 -
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
786PDF: 505HTML: 6291 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1160PDF: 989Suppl. Files: 632HTML: 112 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1228PDF: 588HTML: 399 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1760PDF: 631HTML: 926 -
-
Osteolytic bone lesions – A rare presentation of AML M6.
2095PDF: 1211HTML: 8013Untitled: 251 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
137PDF: 103Suppl. Files: 25Html: 25Html Suppl. Files: 23 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3428PDF: 1791HTML: 1180
1 - 47 of 47 items







